We show that, while ETV1 is expressed at high levels in grade 2 glioma, its expression gradually decreases with glioma stage, and on the other hand, ELK3 and ETV4 expressions are increased with progression of the glioma stage. The gene discussed is ELK3; the disease is central nervous system cancer.